There is one clinical trial.

Clinical Trials

1 Clinical Features of Severe Patients With COVID-19

As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Providing an efficient care to the patients of the most severely affected category — intensive care unit (ICU) patients — has become one of the serious problems appearing in the COVID-19 pandemics. A typical patient's clinical portrait in ICU of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of predictors of severe course of disease can lead to different selection of therapeutic strategy, determine the group of risk of patients for severe course of disease, and improve outcomes.

NCT04450017 SARS-CoV2 Diagnostic Test: The demographic, clinical, laboratory, and instrumental data

No related HPO nodes (Using clinical trials)